Supernus Pharmaceuticals, Inc.

SUPN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001356576

SEC filings (opens in a new tab)

No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Supernus Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of SUPN: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	245	1	273	+29
Shares	58.4M	10.4M	59.9M	+11.9M (+24.8%)
Value	$1.56B	$278.0M	$1.87B	+$583.0M (+45.4%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to SUPN in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	10,066,932	$313.9M	0.01%
Woodline Partners LP	188,571	$5.88M	0.05%
Arrowstreet Capital, Limited Partnership	97,523	$3.04M	0.00%
Trexquant Investment LP	94,952	$2.96M	0.04%
Canada Pension Plan Investment Board	61,700	$1.92M	0.00%
State of New Jersey Common Pension Fund D	56,885	$1.77M	0.01%
PDT Partners, LLC	37,110	$1.16M	0.10%
Systematic Financial Management LP	28,185	$878.8K	0.02%
Quartz Partners, LLC	27,679	$863.0K	0.54%
Tudor Investment Corp Et Al	27,525	$858.2K	0.01%
Segall Bryant & Hamill, LLC	25,377	$791.3K	0.01%
Man Group plc	24,324	$758.4K	0.00%
Exchange Traded Concepts, LLC	21,559	$672.2K	0.02%
Squarepoint Ops LLC	20,967	$653.8K	0.00%
Los Angeles Capital Management LLC	20,033	$624.6K	0.00%
Engineers Gate Manager LP	14,710	$458.7K	0.01%
Dynamic Technology Lab Private Ltd	11,288	$352.0K	0.04%
Shell Asset Management Co	9,342	$291.0K	0.01%
Teza Capital Management LLC	8,898	$277.4K	0.03%
HighTower Advisors, LLC	8,506	$264.0K	0.00%
Boothbay Fund Management, LLC	8,184	$255.2K	0.01%
Quest Partners LLC	7,729	$241.0K	0.02%
Envestnet Portfolio Solutions, Inc.	7,285	$227.1K	0.00%
Pathstone Holdings, LLC	7,148	$222.9K	0.00%
Corton Capital Inc.	6,467	$201.6K	0.10%
Kennebec Savings Bank	3,300	$102.9K	0.10%
Aquatic Capital Management LLC	2,800	$87.3K	0.00%
Acadian Asset Management LLC	1,363	$42.0K	0.00%
GeoWealth Management, LLC	614	$19.1K	0.00%
Kathleen S. Wright Associates Inc.	475	$14.8K	0.01%
Point72 (DIFC) Ltd	455	$14.2K	0.00%
CoreCap Advisors, LLC	300	$9.35K	0.00%
Johnson Financial Group, Inc.	189	$5.89K	0.00%
Sterling Capital Management LLC	167	$5.21K	0.00%
Godsey & Gibb Associates	100	$3.12K	0.00%
True Wealth Design, LLC	97	$3.02K	0.00%
Northwestern Mutual Wealth Management Co	63	$1.96K	0.00%
Picton Mahoney Asset Management	36	$1.00K	0.00%
Capital Performance Advisors LLP	29	$904	0.00%
Ronald Blue Trust, Inc.	24	$642	0.00%
Geneos Wealth Management Inc.	20	$624	0.00%
Continuum Advisory, LLC	17	$615	0.00%
CVA Family Office, LLC	14	$437	0.00%
Legacy Investment Solutions, LLC	8	$303	0.00%
Legacy Wealth Managment, LLC	8	$303	0.00%
Mendota Financial Group, LLC	5	$156	0.00%
TFC Financial Management	1	$32	0.00%
Claris Advisors, LLC	1	$31	0.00%
Hemington Wealth Management	21	$0	0.00%

Sold out (20)

Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of SUPN in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Point72 Asset Management, L.P.	136,342	$3.65M
Edgestream Partners, L.P.	75,843	$2.03M
Jump Financial, LLC	33,770	$903.3K
Virtus Investment Advisers, Inc.	29,148	$779.7K
SG Americas Securities, LLC	18,064	$483.0K
UniSuper Management Pty Ltd	15,072	$403.2K
Centiva Capital, LP	11,719	$313.5K
Occudo Quantitative Strategies LP	7,700	$206.0K
nVerses Capital, LLC	2,700	$72.2K
Newbridge Financial Services Group, Inc.	2,000	$53.5K
Innealta Capital, LLC	1,891	$50.6K
Meeder Asset Management Inc	1,774	$47.5K
Allianz SE	1,400	$37.5K
Virtus Fund Advisers, LLC	878	$23.5K
Raffa Wealth Management, LLC	378	$10.1K
Camelot Portfolios, LLC	200	$5.35K
Tyler-Stone Wealth Management	118	$3.16K
Steward Partners Investment Advisory, LLC	117	$3.13K
Stephens Consulting, LLC	69	$1.85K
RFP Financial Group LLC	27	$722

Not filed for Q3 2024 yet (1)

Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SUPN in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	10,392,636	$278.0M